Related Experiment Video
Updated: May 2, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
LncRNAs: New Players in Apoptosis Control.
Marianna Nicoletta Rossi1, Fabrizio Antonangeli2
1Pasteur Institute-Fondazione Cenci Bolognetti, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Long noncoding RNAs (lncRNAs) regulate crucial cellular processes like apoptosis. Dysregulation of lncRNAs impacts cancer and neurodegeneration, offering potential therapeutic targets and biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The mammalian genome is extensively transcribed, with noncoding RNAs comprising a significant portion of cellular RNA.
- Long noncoding RNAs (lncRNAs) are emerging as key regulators in physiological and pathological processes, including cancer and neurodegeneration.
- Apoptosis, or programmed cell death, is vital for development and homeostasis, and its dysregulation is a hallmark of cancer.
Purpose of the Study:
- To review current research on the role of lncRNAs in apoptosis.
- To highlight the involvement of lncRNAs in cancer cell apoptosis and differentiation.
- To explore the potential of lncRNAs as anticancer drug targets and tumor biomarkers.
Main Methods:
- Literature review of recent studies on lncRNAs and apoptosis.
- Focus on studies involving cancer cells and healthy cells during differentiation.
- Analysis of data correlating lncRNA expression with cancer types.
Main Results:
- lncRNAs are implicated in modulating apoptosis in both physiological and cancer contexts.
- Specific lncRNAs can sensitize cancer cells to apoptosis when overexpressed or downregulated.
- lncRNA expression levels correlate with distinct cancer types.
Conclusions:
- lncRNAs represent a novel class of molecules with significant roles in apoptosis regulation.
- Targeting lncRNAs holds promise for developing new anticancer therapies.
- lncRNAs show potential as diagnostic and prognostic biomarkers for various cancers.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
lncRNA - Long Non-coding RNAs
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Caspases

